Monthly Archives: September 2022

Digital Therapeutics in PAH: Augmenting care journeys for patients with rare, complex chronic disease

PAH-blog-feature-image

Where Big Pharma Stands Recognizing this need, the major players in the PAH treatment space have added a digital solution to their portfolio. This first wave of solutions provide tracking of symptoms, education on the disease, interaction with devices such as nebulizers, and monitoring of emotional wellbeing. There is still an opportunity to go deeper

Lung Cancer: Addressing Gaps in Care for this Serious Non-Chronic Medical Condition Through Digital Therapeutics

lung-cancer-blog

Introduction More than half the people die within the first year of being diagnosed with Lung Cancer. The American Cancer Society’s estimates for lung cancer in the United States for 2022 are about 236,740 new cases and about 130,180 deaths. Lung Cancer is directly responsible for loss of income, increased health-related costs, morbidity, and mortality